Statements (50)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:belongs_to |
gptkb:Flaviviridae
|
gptkbp:caused_by |
gptkb:healthcare_organization
|
gptkbp:communication |
gptkb:healthcare_organization
|
gptkbp:discovered_by |
gptkb:1989
|
gptkbp:has |
gptkb:none
|
gptkbp:has_style |
gptkb:HCV-2
HCV-1 HCV-3 HCV-4 HCV-5 HCV-6 |
https://www.w3.org/2000/01/rdf-schema#label |
Hepacivirus
|
gptkbp:is_associated_with |
liver disease
liver cancer cirrhosis |
gptkbp:is_part_of |
gptkb:healthcare_organization
chronic disease management public health initiatives healthcare policy discussions infectious disease control global health strategies clinical guidelines for hepatitis C liver health awareness campaigns viral hepatitis elimination efforts |
gptkbp:is_protected_by |
safe sex practices
screening blood donations safe injection practices |
gptkbp:is_related_to |
HCV genotype
HCV treatment response HCV viral load |
gptkbp:is_studied_in |
gptkb:hospital
genetic diversity epidemiology vaccine development transmission dynamics new antiviral drugs |
gptkbp:recognizes |
gptkb:Person
primates |
gptkbp:scientific_classification |
hepatotropic virus
|
gptkbp:seed_dispersal |
gptkb:CEO
|
gptkbp:social_responsibility |
blood tests
|
gptkbp:symptoms |
fatigue
nausea abdominal pain jaundice loss of appetite |
gptkbp:treatment |
antiviral therapy
|
gptkbp:bfsParent |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
3
|